{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:38:07Z","timestamp":1784806687518,"version":"3.55.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019718","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Partnering for Innovation and Excellence in Rare Skin Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Generalized pustular psoriasis (GPP) is a chronic, systemic, neutrophilic inflammatory disease. A previous Delphi panel established areas of consensus on GPP, although patient perspectives were not included and aspects of treatment goals remained unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To identify and achieve consensus on refined, specific treatment goals for GPP treatment via a Delphi panel with patient participation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Statements were generated based on a systematic literature review and revised by a Steering Committee. Statements were categorized into overarching principles, and short- and long-term treatment goals. A global panel of 30 dermatologists and 3 patient representatives voted in agreement or disagreement with each statement. Consensus was defined as \u2265 80% approval by the panellists.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Consensus was reached in the first round of voting and \u2265 90% agreement was reached for 23 of 26 statements. In summary, GPP requires a timely, tailored treatment plan, co-developed by patients and physicians, that involves a multidisciplinary approach and addresses the complexity, heterogeneity and chronicity of the disease. Short-term treatment goals should include pustule clearance within 7\u2005days and prevention of pustule recurrence, reduction of cutaneous symptom burden (\u22124 or more points on the Itch and Skin Pain Numeric Rating Scale), improvement in systemic symptoms (e.g. resolution of fever within 3\u2005days of treatment initiation and reduced fatigue), prevention of life-threatening complications and progressive improvement of inflammatory biomarkers. In patients with comorbid psoriatic diseases, treatment decisions should prioritize GPP. Long-term treatment goals should include minimizing disease activity through flare prevention and symptom control between flares, sustained disease control, management of comorbidities and improvement in quality of life (QoL). Small differences in perception between patients and physicians regarding the importance of certain treatment goals (e.g. avoiding hair and\/or nail loss to improve QoL), reflect the complexity of assessing treatment goals and emphasize the need for a patient-centred approach.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In the first global Delphi panel in GPP to include patient perspectives, consensus between dermatologists and patients was achieved on overarching principles of treatment, and short- and long-term treatment goals for GPP. These findings provide valuable insights for developing guidelines that consider the perspectives of patients and physicians in the treatment of GPP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljae491","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T05:31:16Z","timestamp":1737610276000},"page":"706-716","source":"Crossref","is-referenced-by-count":13,"title":["Global Delphi consensus on treatment goals for generalized pustular psoriasis"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-183X","authenticated-orcid":false,"given":"Jonathan N","family":"Barker","sequence":"first","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Faculty of Life Sciences and Medicine, King\u2019s College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmylou","family":"Casanova","sequence":"additional","affiliation":[{"name":"Patient author"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7796-5746","authenticated-orcid":false,"given":"Siew Eng","family":"Choon","sequence":"additional","affiliation":[{"name":"Hospital Sultanah Aminah Johor Bahru, Clinical School Johor Bahru, Monash University , Subang Jaya ,","place":["Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Foley","sequence":"additional","affiliation":[{"name":"Skin Health Institute and The University of Melbourne, St Vincent\u2019s Hospital Melbourne , Melbourne ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Clinica Universitaria Colombia , Bogot\u00e1 ,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Gooderham","sequence":"additional","affiliation":[{"name":"SKiN Center for Dermatology and Queen\u2019s University , Peterborough, ON ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slaheddine","family":"Marrakchi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hedi Chaker University Hospital , Sfax ,","place":["Tunisia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Romiti","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of S\u00e3o Paulo , S\u00e3o Paulo ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8513-550X","authenticated-orcid":false,"given":"Diamant","family":"Tha\u00e7i","sequence":"additional","affiliation":[{"name":"Institute and Comprehensive Center for Inflammation Medicine, University of L\u00fcbeck , L\u00fcbeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Second Affiliated Hospital, Zhejiang University , Hangzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8394-2057","authenticated-orcid":false,"given":"Bruce","family":"Strober","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale University , New Haven, CT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Partnering for Innovation and Excellence in Rare Skin Diseases (PIONEERS\u00ae) Working Group and the DELPHI Panel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Magari\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahira","family":"El Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzlina Binti","family":"Che Yaacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Prignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong","family":"Jin Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van der Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmylou","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Schmitt-Egenolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Bulbul Baskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Burden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Reisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Eyerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Stratigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev","family":"Pavlovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfina Guadalupe","family":"Villanueva Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Imafuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azura","family":"Affandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Manuel Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marni","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuelle-Anne","family":"Viguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Bhutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025031819362086300_ljae491-B1","doi-asserted-by":"crossref","first-page":"adv00034","DOI":"10.2340\/00015555-3388","article-title":"Pustular psoriasis: the dawn of a new era","volume":"100","author":"Bachelez","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"2025031819362086300_ljae491-B2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40257-021-00664-x","article-title":"The prevalence and disease characteristics of generalized pustular psoriasis","volume":"23","author":"Zheng","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"2025031819362086300_ljae491-B3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jaad.2023.09.080","article-title":"Generalized pustular psoriasis: a consensus statement from the National Psoriasis Foundation","volume":"90","author":"Armstrong","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2025031819362086300_ljae491-B4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/1346-8138.14523","article-title":"Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP","volume":"45","author":"Fujita","year":"2018","journal-title":"J Dermatol"},{"key":"2025031819362086300_ljae491-B5","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025031819362086300_ljae491-B6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jdv.18851","article-title":"Generalized pustular psoriasis: a global Delphi consensus on clinical course, diagnosis, treatment goals and disease management","volume":"37","author":"Puig","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025031819362086300_ljae491-B7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jamadermatol.2022.3142","article-title":"Understanding flares in patients with generalized pustular psoriasis documented in US electronic health records","volume":"158","author":"Zema","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2025031819362086300_ljae491-B8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40257-021-00654-z","article-title":"Clinical course and characteristics of generalized pustular psoriasis","volume":"23","author":"Choon","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"2025031819362086300_ljae491-B9","doi-asserted-by":"crossref","article-title":"Generalized pustular psoriasis (GPP) continues to adversely impact quality of life between flares, as per Dermatology Life Quality Index scores: baseline data from the Effisayil 2 trial","author":"Augustin","DOI":"10.1016\/j.jaad.2024.07.873"},{"key":"2025031819362086300_ljae491-B10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40257-021-00663-y","article-title":"Impact of generalized pustular psoriasis from the perspective of people living with the condition: results of an online survey","volume":"23","author":"Reisner","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"2025031819362086300_ljae491-B11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13555-021-00493-0","article-title":"Unmet medical needs in the treatment and management of generalized pustular psoriasis flares: evidence from a survey of Corrona registry dermatologists","volume":"11","author":"Strober","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025031819362086300_ljae491-B12","article-title":"Symptom and impact experience of adults with generalized pustular psoriasis (GPP) or palmoplantar pustulosis (PPP): an international web survey and qualitative interview study","author":"Lebwohl"},{"key":"2025031819362086300_ljae491-B13","doi-asserted-by":"crossref","first-page":"AB20","DOI":"10.1016\/j.jaad.2021.06.107","article-title":"Characterization of flares in patients with generalized pustular psoriasis: a population-based study from the French National Health Data System database (SNDS)","volume":"85","author":"Bachelez","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025031819362086300_ljae491-B14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40257-021-00658-9","article-title":"Treatment options and goals for patients with generalized pustular psoriasis","volume":"23","author":"Krueger","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"2025031819362086300_ljae491-B15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2016.08.056","article-title":"IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis","volume":"140","author":"Johnston","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025031819362086300_ljae491-B16","doi-asserted-by":"crossref","first-page":"AB108","DOI":"10.1016\/j.jaad.2021.06.451","article-title":"Patient-reported outcomes from a large, North American-based cohort, highlight a greater disease burden for generalized pustular psoriasis vs plaque psoriasis: real-world evidence from the Corrona Psoriasis Registry","volume":"85","author":"Strober","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025031819362086300_ljae491-B17","doi-asserted-by":"crossref","article-title":"Real-world treatment patterns in patients with generalized pustular psoriasis: results from a US claims analysis","author":"Strober","DOI":"10.1016\/j.jaad.2024.07.1174"},{"key":"2025031819362086300_ljae491-B18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/1744666X.2022.2116003","article-title":"Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion","volume":"18","author":"Bachelez","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"2025031819362086300_ljae491-B19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamadermatol.2024.0915","article-title":"International consensus definition and diagnostic criteria for generalized pustular psoriasis from the International Psoriasis Council","volume":"160","author":"Choon","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2025031819362086300_ljae491-B20","doi-asserted-by":"crossref","first-page":"FRD36","DOI":"10.2217\/frd-2022-0018","article-title":"Patient\u2013dermatologist gap in perception of disease burden and treatment of generalized pustular psoriasis in Japan","volume":"3","author":"Yagi","year":"2023","journal-title":"Future Rare Dis"},{"key":"2025031819362086300_ljae491-B21","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/exd.14765","article-title":"Current management of generalized pustular psoriasis","volume":"32","author":"Kodali","year":"2023","journal-title":"Exp Dermatol"},{"key":"2025031819362086300_ljae491-B22","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s13555-024-01230-z","article-title":"Current treatments for generalized pustular psoriasis: a narrative summary of a systematic literature search","volume":"14","author":"Puig","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025031819362086300_ljae491-B23","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","article-title":"Trial of spesolimab for generalized pustular psoriasis","volume":"385","author":"Bachelez","year":"2021","journal-title":"N Engl J Med"},{"key":"2025031819362086300_ljae491-B24","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(23)01378-8","article-title":"Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial","volume":"402","author":"Morita","year":"2023","journal-title":"Lancet"},{"key":"2025031819362086300_ljae491-B25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13555-021-00661-2","article-title":"Unmet educational needs and clinical practice gaps in the management of generalized pustular psoriasis: global perspectives from the front line","volume":"12","author":"Strober","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025031819362086300_ljae491-B26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s13555-022-00736-8","article-title":"Symptom experience and content validity of the Psoriasis Symptom Scale (PSS) in patients with generalized pustular psoriasis (GPP)","volume":"12","author":"Burden","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025031819362086300_ljae491-B27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000529274","article-title":"Clinical characteristics and outcomes of generalized pustular psoriasis flares","volume":"239","author":"Choon","year":"2023","journal-title":"Dermatology"},{"key":"2025031819362086300_ljae491-B28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamadermatol.2021.4640","article-title":"Evaluation of a case series of patients with generalized pustular psoriasis in the United States","volume":"158","author":"Noe","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2025031819362086300_ljae491-B29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3390\/vaccines11040740","article-title":"Characteristics of patients experiencing a flare of generalized pustular psoriasis: a multicenter observational study","volume":"11","author":"Bellinato","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2025031819362086300_ljae491-B30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40257-021-00652-1","article-title":"Diagnosis of generalized pustular psoriasis","volume":"23","author":"Fujita","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"2025031819362086300_ljae491-B31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jdv.18720","article-title":"Prevalence, comorbidities and mortality of generalized pustular psoriasis: a literature review","volume":"37","author":"Prinz","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025031819362086300_ljae491-B32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/1744666X.2019.1648209","article-title":"An update on generalized pustular psoriasis","volume":"15","author":"Gooderham","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2025031819362086300_ljae491-B33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s13555-022-00881-0","article-title":"Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment","volume":"13","author":"Rivera-D\u00edaz","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025031819362086300_ljae491-B34","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s00403-002-0371-6","article-title":"Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity","volume":"295","author":"Umezawa","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"2025031819362086300_ljae491-B35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000512688","article-title":"The impact of nail psoriasis and treatment on quality of life: a systematic review","volume":"7","author":"Stewart","year":"2021","journal-title":"Skin Appendage Disord"},{"key":"2025031819362086300_ljae491-B36","article-title":"Effect of spesolimab on achieving sustained disease remission in patients with generalized pustular psoriasis: results from the Effisayil 2 study","author":"Gordon"},{"key":"2025031819362086300_ljae491-B37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/jdv.19530","article-title":"Health-related quality of life in patients with generalized pustular psoriasis: a systematic literature review","volume":"38","author":"Choon","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025031819362086300_ljae491-B38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/jdv.19901","article-title":"Generalized pustular psoriasis: a nationwide population-based study using the National Health Data System in France","volume":"38","author":"Viguier","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025031819362086300_ljae491-B39","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/exd.14794","article-title":"Diversity in the clinical presentation of generalized pustular psoriasis (GPP): a series of case vignettes from around the world","volume":"32","author":"Choon","year":"2023","journal-title":"Exp Dermatol"},{"key":"2025031819362086300_ljae491-B40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","article-title":"AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking","volume":"94","author":"Setta-Kaffetzi","year":"2014","journal-title":"Am J Hum Genet"},{"key":"2025031819362086300_ljae491-B41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00403-015-1611-x","article-title":"Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients","volume":"308","author":"Wang","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"2025031819362086300_ljae491-B42","first-page":"687","article-title":"Patients as partners in rare disease diagnosis and research","volume":"94","author":"McCray","year":"2021","journal-title":"Yale J Biol Med"},{"key":"2025031819362086300_ljae491-B43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdin.2023.12.008","article-title":"Poor adherence to and persistence with biologics in generalized pustular psoriasis: a claim-based study using real-world data from two large US databases","volume":"15","author":"Feldman","year":"2024","journal-title":"JAAD Int"},{"key":"2025031819362086300_ljae491-B44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jvc2.379","article-title":"Adherence to treatment in dermatology: literature review","volume":"3","author":"Lo","year":"2024","journal-title":"JEADV Clin Pract"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae491\/61573256\/ljae491.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/4\/706\/61573256\/ljae491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/192\/4\/706\/61573256\/ljae491.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T19:36:43Z","timestamp":1742326603000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/192\/4\/706\/7973903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,1,23]]},"published-print":{"date-parts":[[2025,3,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae491","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,1,23]]}}}